RC By Rachel Cohrs Zhang, Madison Muller and Naomi Kresge, Bloomberg November 06, 2025 12:00 PM CST Featured Stories Providers How Risant-owned Cone Health plans to grow under new CEO Cone Health is a relatively small system in North Carolina, surrounded by heavyweights such as Advocate Health and UNC Health
1 Study Flow Diagram for Selecting Patients Initiating Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) or Dipeptidyl Peptidase-4 Inhibitor (DPP-4i)
Most patients who stop GLP-1 treatment regain a significant portion of the weight they lost, which is why discontinuation is generally not recommended unless side effects or other clinical concerns warrant it
What are the side effects of GLP-1 agonists
The adoption of large-scale collaborative research, standardization of definitions and analyses, pilot examination of interventions, and improvement in study design standards, peer review, reporting, and dissemination of research have been identified as crucial actions to enhance the validity of scientific works (302)
2022;387:205-216.) 2 120g 3 3 23OK30 D 4 GLP-1 24 5 6 GLP-1 3 1P 2 3 1 GLP-1 3 OK 4 // 8241 36 GLP-1 GLP-1 045-755-3039 [email protected] My427-1 LINE : My
,aspect=fit)
